FDA OKs Warner Chilcott's Atelvia for postmenopausal osteoporosis

10/11/2010 | Reuters

The FDA has approved Atelvia, Warner Chilcott's treatment for osteoporosis in postmenopausal women. The delayed-release tablet belongs to the Actonel family of bone drugs that Warner Chilcott purchased last year from Procter & Gamble.

View Full Article in:

Reuters

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
In house Compliance Officer
Confidential
Pompano Beach, FL
Clinical Project Manager
Abiomed, Inc.
Danvers, MA
Sr. Manager, Regulatory Affairs - International
Integra LifeSciences
Plainsboro, NJ
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
Director, Site Quality Management
CareFusion
Minneapolis, MN